Market Closed -
Other stock markets
|
After market 23:30:10 | |||
152.7 USD | +0.37% |
|
152 | -0.44% |
06-26 | Monetary policy is getting even more confusing | ![]() |
06-26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.32% | 14.38B | |
+20.63% | 126B | |
+24.16% | 27.95B | |
-20.17% | 20.5B | |
-16.06% | 17.12B | |
-18.07% | 16.1B | |
-47.70% | 14.97B | |
+11.92% | 14.84B | |
+149.98% | 12.37B | |
-10.27% | 9.91B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Transcript : Sarepta Therapeutics, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-10-2017 07